Ministerio de Ciencia e Innovación

Call for Proposals 2025 pre-announcement

The European Rare Diseases Research Alliance (ERDERA) is excited to announce the upcoming launch of its Joint Transnational Call (JTC) for Proposals 2025. Set to officially open on December 10, 2024, this call will invite research teams from across Europe and beyond to submit collaborative projects focused on “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation”.

Aim of the Call. The primary objective is to support interdisciplinary, transnational collaborations that leverage complementary expertise to develop new therapies for rare diseases. Research projects should focus on pre-clinical studies involving small molecules or biologicals. This could include the development of novel therapies, biomarkers for therapy efficiency, or replication of pre-clinical studies to validate findings. Please note that this is a draft announcement and the list of funders is not final.

Topics of Interest. Eligible proposals may include research on:

  • Development of pre-clinical therapies using cell, organoid, or animal models.
  • Biomarker identification that correlates with therapeutic efficacy.
  • Pre-clinical proof-of-concept studies showing pharmacological activity and safety data.

    Notably, gene therapies, rare neurodegenerative diseases like Alzheimer’s, and rare cancers are excluded from this call. Projects should have a special focus on therapies that can translate into clinical applications.

Spanish funding organization: In Spain the call is supposed to open with the involvement of the National Institute of Health Carlos III (ISCIII). Please note that national eligibility criteria should be revised when the call officially opens.

Application Timeline. The JTC 2025 will follow a two-stage submission process:

  • December 10, 2024: Call opens.
  • February 13, 2025: Pre-proposal submission deadline.
  • July 9, 2025: Full proposal submission deadline. Funding decisions are expected by December 2025.

Get Involved. Interested applicants can join an informational webinar on December 17, 2024, for guidance on preparing submissions. Additionally, partnerships with patient advocacy organizations (PAOs) and the inclusion of Early Career Researchers (ECRs) are highly encouraged to foster a collaborative and inclusive research environment.

For further details, please contact the Joint Call Secretariat at [email protected] or the relevant national contact point. Stay tuned for more information on this exciting opportunity to drive forward research in rare disease therapies!

More information: Pre-announcement JTC 2025

 

 

Entidad financiadora: Joint Transnational Call (JTC) for Proposals 2025

Plazo de presentación: 

- December 10, 2024: Call opens.

- February 13, 2025: Pre-proposal submission deadline.

- July 9, 2025: Full proposal submission deadline. 

Documentación: Ver adjunto

Entidad Financiadora: Joint Transnational Call (JTC) for Proposals 2025

Volver al Listado